Infratrac Inc.
Hagerstown, MD
- UEI
- SYELB4K7LDE8
- CAGE
- 551B9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 20140 Scholar Dr #118, Hagerstown, MD 21742, USA
- Website
- infratrac.com
- Founded
- 2006
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Materials
- Chemicals
- Commodity Chemicals
- SIC code
- 73 Business Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| B & W TEK Inc. | Newark, DE | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
About the company
Infratrac Inc. is a woman-owned small business that uses light-activated chemical signatures to defeat counterfeiters, verify 3D printed products, and improve controlled release of drugs and other products. According to its website, Infratrac uses "the power of light to defeat counterfeiters, verify 3D printed products, and improve controlled release."
Through multiple cooperative agreements and grants from the Department of Commerce National Institute of Standards and Technology (NIST) and the Department of Health and Human Services National Institutes of Health (NIH), Infratrac has developed techniques to enhance trust, safety, and quality control for personalized medicine delivered through 3D printed drugs. Notable projects include a $400,000 NIST award for Phase II research building on Phase I work to create enforceable quality parameters for 3D printed drugs accommodating personalized dosing. Infratrac expanded its R&D scope to include more drugs, doses, and failure types, integrating detection and prediction into a commercially-viable process control tool. Subcontractors were the University of Maryland School of Pharmacy and FabRx, a 3D pharmaceutical printing company. Another NIST award for $200,000 funded development of a near-infrared spectroscopy technique to identify biomolecules and assess pharmaceutical quality for in-process monitoring of 3D drug printing. Infratrac also received a $907,932 NIH grant to design and engineer biodegradable 3D nanoprinted microcarriers offering extended drug release profiles tailored to patient needs like HIV treatment regimens.
SBA capabilities narrative
Chemical security fingerprinting for anti-counterfeiting and brand protection, including for additive manufacturing, 3D printing. Taggant authentication via spectroscopy, tracked via blockchain.
Quick answers
Is Infratrac Inc. registered in SAM.gov?
Yes. Infratrac Inc.'s SAM.gov registration is active through April 29, 2027.
What is Infratrac Inc.'s most recent federal award?
Infratrac Inc.'s most recent federal grant award is Infratrac believes that personalized medicine can be developed using point-of-care drug printing. During its phase II… (70NANB23H209), from National Institute of Standards and Technology, on October 1, 2023.
On GovTribe
See Infratrac Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors